In relation to GBM, Rebastinib can successfully inhibit tumor growth and prolong survival by targeting an N-terminal truncated form of p75 (ΔNp73), which transcriptionally regulates both Tie2 and Ang-2 in concert with ETS2 proteins [304]. Here, TEK is linked to glioblastoma.